SRSF9 and ovarian cancer: Their studies showed that exosomes from ovarian cancer cell lines carrying PANDAR increased the SIRT4/SIRT6 mRNA proportion in ovarian cancer cells by interacting with the target gene SRSF9, significantly enhancing tumor cell survival and chemotherapy resistance in vitro [113].